Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPLZL.L Regulatory News (PLZL)

  • There is currently no data for PLZL

Rule 8.1- OJSC Polyus Gold

1 Jul 2009 11:50

RNS Number : 9065U
Renaissance Capital Limited
01 July 2009
Β 

ο»Ώ

Β  FORM 8.1

DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES

FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

(RulesΒ 8.1(a) and (b)(i)Β ofΒ theΒ TakeoverΒ Code)

1. KEY INFORMATION

Name of person dealingΒ (Note 1)

Subsidiaries of Renaissance Capital Holdings Limited trading under theΒ Renaissance CapitalΒ brand

Company dealt in

OJSC Polyus Gold

Class of relevant security to which the dealings being disclosed relateΒ (NoteΒ 2)

1 RUB ordinary (OJSC Polyus Gold)

Date of dealing

30Β June 2009

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) InterestsΒ and short positionsΒ (following dealing) in the class of relevant security dealt inΒ (Note 3)

Long

Short

Number (%)

Number (%)

(1) Relevant securitiesΒ 

250,249.50 (0.13%)

224,406 (0.12%)

(2) Derivatives (other than options)

1,240,000 (0.65%)

(3) Options and agreements to purchase/sell

Total

250,249.50 (0.13%)

1,494,406 (0.78%)

(b) InterestsΒ and short positionsΒ in relevant securities of the company, other than theΒ classΒ dealt inΒ (Note 3)

Class of relevant security:

Long

Short

Number (%)

Number (%)

(1) Relevant securitiesΒ 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

(c) Rights to subscribeΒ (Note 3)

Class of relevant security:

Details

3. DEALINGSΒ (Note 4)

(a) Purchases and sales

Total number of securities purchased

Highest price paidΒ (Note 3)

Lowest price paidΒ (Note 3)

10,273Β ordinary shares

395,605Β ordinary shares

USDΒ 39.945

RURΒ 1236.500

USDΒ 38.101

RURΒ 845.582

Total number of securities sold

Highest price receivedΒ (Note 3)

Lowest price receivedΒ (Note 3)

414,376Β ordinary shares

61,837Β ADRs (conversion ratio 1 ADR:0.5 share)

RURΒ 1249.850

USDΒ 20.697

RURΒ 845.582

USDΒ 19.980

(b) Derivatives transactions (other than options)

Product name,Β 

e.g. CFD

Long/shortΒ (Note 6)

Number of securitiesΒ (Note 7)

Price per unitΒ (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g.Β callΒ option

Writing, selling, purchasing, varying etc.

Number of securitiesΒ to which the option relatesΒ (Note 7)

Exercise

priceΒ 

Type,Β e.g. American, European etc.

ExpiryΒ 

date

Option money

paid/receivedΒ per unitΒ (Note 5)

(ii) Exercising

Product name,Β e.g.Β call option

Number of securitiesΒ 

Exercise priceΒ per unitΒ (Note 5)

(d) Other dealings (including new securities)Β (Note 4)

Nature of transactionΒ (Note 8)

Details

PriceΒ per unitΒ (if applicable)Β (Note 5)Β 

Β 

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingΒ toΒ the voting rights of any relevant securities under any option referred to on this form orΒ relating to the voting rights orΒ future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached?Β (Note 9) YES

Date of disclosure

1 JulyΒ 2009

Contact name

Bridget Andrews

Telephone number

020 7367 7988

Name of offeree/offerorΒ with whichΒ associated

Jenington International Inc (an indirect wholly owned subsidiary of OJSC Polyus Gold)Β 

Specify category and nature of associate statusΒ (Note 10)

Acting in concertΒ as a result of a 50%Β less one-half of one shareΒ ownership of Renaissance Financial Holdings Limited by ONEXIM Group.

Notes

TheΒ NotesΒ onΒ Form 8.1 can be viewed on the Takeover Panel's website atΒ www.thetakeoverpanel.org.uk

Β 

SUPPLEMENTAL FORM 8

DETAILS OF OPENΒ POSITIONSΒ 

(This form should be attached to Form 8.1, Form 8.1(b)(ii)Β or Form 8.3, as appropriate)

OPENΒ POSITIONSΒ (NoteΒ 1)

Product name,

e.g.Β call option

Written or purchased

Number of securitiesΒ to which the option or derivative relates

Exercise priceΒ (Note 2)

Type, e.g. American, European etc.

Expiry date

Β Total return swap

Written

1,750,000 ADRs

Market price at termination date

Traders agreed on securities settlement - confirmation stated cash settled

24 November 2009

Total return swap

Written

730,000 ADRs

Market price at termination date

Traders agreed on securities settlement - confirmation stated cash settled

17 July 2009

Notes

1.Β Where there are open option positions or open derivative positions (except for CFDs), full details should be given.Β Β Full details of anyΒ Β existing agreements to purchase or to sellΒ Β shouldΒ also be given on this form.Β Β 

2. For all prices and other monetary amounts, the currency must be stated.

For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the Takeover Panel's website atΒ www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DCCBFLFBKDBZBBD
Date   Source Headline
29th May 20181:47 pmRNSPolyus signs $70 million credit facility from ING
25th May 20182:43 pmRNSFinancial Results for 1Q 2018
21st May 201810:47 amRNSNatalka mill operates at above 80% of capacity
18th May 201812:41 pmRNSConvertible Bonds Admitted to Trading
18th May 201812:33 pmRNSConvertible Bonds Admitted to Trading
30th Apr 20187:00 amRNSNotice of 2017 Annual Report and AGM
27th Apr 201812:58 pmRNS2H 2017 Dividend Recommendation
25th Apr 20184:00 pmRNSDisclosure of transactions by PDMR
25th Apr 20181:34 pmRNSDirector/PDMR Shareholding
23rd Apr 20184:49 pmRNSDirector/PDMR Shareholding
18th Apr 20185:22 pmRNSDirector/PDMR Shareholding
17th Apr 20187:00 amRNSTrading update for 1Q 2018
13th Apr 20186:27 pmRNSAnnouncement of results
12th Apr 20181:50 pmRNSAnnouncement on convertible bonds purchase
20th Mar 20181:03 pmRNSDirector/PDMR Shareholding
20th Mar 20189:10 amRNSOre Reserves and Mineral Resources Update
20th Mar 20188:50 amRNSCapital Markets Day, Corporate Update
15th Feb 20187:00 amRNSAnnual Financial Report
9th Feb 20181:33 pmRNSFinancial Results for the Year 2017
29th Jan 20185:26 pmRNSClosing of USD 500 million Eurobonds offering
29th Jan 20185:20 pmRNSClosing of USD 500 million Eurobonds offering
25th Jan 20187:00 amRNSPricing of USD 500 million Eurobonds
23rd Jan 20186:27 pmRNSNotification and public disclosure of transactions
22nd Jan 20187:03 amRNSUSD250 million Convertible Bonds Placement
22nd Jan 20187:00 amRNSU.S.$250 million Convertible Bonds Placement
19th Jan 20187:06 amRNS$250 million offering of Convertible Bonds
17th Jan 201812:50 pmRNSAmendment to the Dividend Policy
16th Jan 20187:01 amRNSTrading update 4Q17
15th Jan 20188:13 amRNSTermination of Agreement with Fosun
4th Dec 201711:20 amRNSFirst Doré gold poured at Natalka
1st Dec 20172:38 pmRNSAppointment of New Board Members of Polyus
21st Nov 20177:36 amRNSPolyus Starts Drilling Campaign at Sukhoi Log
14th Nov 201711:25 amRNSPolyus shares to be included in MSCI Russia index
9th Nov 20177:00 amRNSFinancial Results for 3Q and 9M 2017
30th Oct 20172:08 pmRNSNotice of 3Q 2017 Financial Results
6th Oct 20174:07 pmRNSFurther Guarantee under the 2013 Notes
4th Oct 20171:43 pmRNSMaria Gordon nominated as new Independent Director
28th Sep 20173:22 pmRNSFitch Affirms Polyus "BB-" rating
18th Sep 20173:50 pmRNSPolyus EGM approves dividend for 1H 2017
5th Sep 20172:42 pmRNSPolyus starts commissioning of Natalka
31st Aug 20174:21 pmRNSNotice to holders of RegS Global Depositary Shares
15th Aug 20172:50 pmRNSNotice of GM
14th Aug 20178:01 amRNSFinancial Results for 1H 2017
14th Aug 20177:44 amRNS1H 2017 Dividend Recommendation
11th Aug 20178:47 amRNSTrading update 2Q17
7th Aug 20174:01 pmRNSNotice of 1H 2017 Financial Results
2nd Aug 20171:13 pmRNSResults of the Offering
28th Jul 20175:53 pmRNSEnd of Stabilisation Notice
28th Jul 20174:09 pmRNSNotification of transactions by PDMR
12th Jul 20172:31 pmRNSReplacement: Polyus entered into option agreements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.